1 tracked superinvestor hold ARS PHARMACEUTICALS INC (SPRY), worth $8M combined, led by Daniel Loeb. Smart money is accumulating SPRY as of the latest 13F filings.
Current price
$7.88
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Market cap
$850M
P/E
-4.92
Div yield
0.0%
Revenue YoY
-5.5%
Analyst target
$26
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$8M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating SPRY: 1 funds added or opened versus 0 trimming.
ARS PHARMACEUTICALS INC (SPRY) is held by 1 tracked funds worth $8M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Daniel Loeb at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 0 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Added | 0.4% | $8M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own SPRY?
1 tracked funds hold ARS PHARMACEUTICALS INC (SPRY), the largest being Daniel Loeb (Third Point) at 0.4% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling SPRY?
In the most recent 13F quarter, 1 tracked fund added or opened SPRY and 0 trimmed it.
How much SPRY do tracked funds hold?
Combined disclosed long exposure to SPRY across tracked superinvestors is $8M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.